Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tsukagoshi

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1995
[Porfimer sodium (Photofrin-II)]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1993
[Development of antimetabolites, II]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1992
[Hydrea, an effective drug for chronic myelogenous leukemia]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1990
[Epirubicin (4'-epi-adriamycin]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1987
[A new anticancer drug, 5'-deoxy-5-fluorouridine (5'-DFUR)]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1987
[Introduction of a new anticancer drug, novantrone]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1987
[A new antitumor drug with immunomodulating activity, ubenimex (bestatin)]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2000
[Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 30, 2001
[Results of gemcitabine hydrochloride in the treatment for pancreatic cancer]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1995
[From the aspect of pre-clinical study of new anticancer candidate compounds]S Tsukagoshi
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1995
[Porfimer sodium (Photofrin-II)]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1993
[Development of antimetabolites, II]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1992
[Hydrea, an effective drug for chronic myelogenous leukemia]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1990
[Epirubicin (4'-epi-adriamycin]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1987
[A new anticancer drug, 5'-deoxy-5-fluorouridine (5'-DFUR)]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1987
[Introduction of a new anticancer drug, novantrone]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1987
[A new antitumor drug with immunomodulating activity, ubenimex (bestatin)]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2000
[Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 30, 2001
[Results of gemcitabine hydrochloride in the treatment for pancreatic cancer]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1995
[From the aspect of pre-clinical study of new anticancer candidate compounds]S Tsukagoshi
Pageof 18